Neurological Soft Signs in Schizophrenia: A Meta-analysis

• Published in: Schizophrenia bulletin Vol. 36; no. 6; pp. 1089 - 1104
• Main Authors: CHAN, Raymond C. K, TING XU, HEINRICHS, R. Walter, YUE YU, YA WANG
• Format: Journal Article
• Language: English
• Published: Oxford Oxford University Press 01-11-2010
• Subjects: Adult and adolescent clinical studies; Biological and medical sciences; Case-Control Studies; Cognition; Endophenotypes; Family - psychology; Humans; Medical sciences; Neurologic Examination; Prevalence; Psychology. Psychoanalysis. Psychiatry; Psychomotor Performance; Psychopathology. Psychiatry; Psychoses; Regular; Schizophrenia; Schizophrenia - diagnosis; Schizophrenia - genetics; Schizophrenic Psychology; Sensitivity and Specificity; Psychosis; Neurological soft sign; neurological soft signs; Schizophrenia; meta-analysis; Review; Metaanalysis
• ISSN: 0586-7614; 1745-1701
• DOI: 10.1093/schbul/sbp011

Neurological soft signs (NSS) are hypothesized as candidate endophenotypes for schizophrenia, but their prevalence and relations with clinical and demographic data are unknown. The authors undertook a quantification (meta-analysis) of the published literature on NSS in patients with schizophrenia and healthy controls. A systematic search was conducted for published articles reporting NSS and related data using standard measures in schizophrenia and healthy comparison groups.
A systematic search was conducted for published articles reporting data on the prevalence of NSS in schizophrenia using standard clinical rating scales and healthy comparison groups. Meta-analyses were performed using the Comprehensive Meta-analysis software package. Effect sizes (Cohen d) indexing the difference between schizophrenic patients and the healthy controls were calculated on the basis of reported statistics. Potential moderator variables evaluated included age of patient samples, level of education, sample sex proportions, medication doses, and negative and positive symptoms.
A total of 33 articles met inclusion criteria for the meta-analysis. A large and reliable group difference (Cohen d) indicated that, on average, a majority of patients (73%) perform outside the range of healthy subjects on aggregate NSS measures. Cognitive performance and positive and negative symptoms share 2%-10% of their variance with NSS.
NSS occur in a majority of the schizophrenia patient population and are largely distinct from symptomatic and cognitive features of the illness.